KYRNF (Kyorin Pharmaceutical Co) Cyclically Adjusted Book per Share: $15.21 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KYRNF Kyorin Pharmaceutical Co Ltd KYRNF
74 GF Score
Price $10.31
GF Value $13.86
! 6 Warning Signs
View Full Analysis

What is Kyorin Pharmaceutical Co Cyclically Adjusted Book per Share?

Kyorin Pharmaceutical Co KYRNF 74 Cyclically Adjusted Book per Share is $15.21 as of Mar. 2026. GuruFocus rates KYRNF with a GF Score™ of 74/100 and a GF Value™ of $13.86. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kyorin Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was $15.624. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $15.21 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Kyorin Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 1.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Kyorin Pharmaceutical Co was 4.40% per year. The lowest was 3.20% per year. And the median was 3.90% per year.

As of today (2026-08-02), Kyorin Pharmaceutical Co's current stock price is $10.31. Kyorin Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $15.21. Kyorin Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 0.68.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kyorin Pharmaceutical Co was 1.47. The lowest was 0.45. And the median was 0.88.


Kyorin Pharmaceutical Co  (OTCPK:KYRNF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kyorin Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.31/15.21
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kyorin Pharmaceutical Co was 1.47. The lowest was 0.45. And the median was 0.88.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kyorin Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Kyorin Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Kyorin Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyorin Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Kyorin Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.93 24.04 23.43 16.66 15.21

Kyorin Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.66 16.61 17.07 16.57 15.21

KYRNF vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kyorin Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyorin Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyorin Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kyorin Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


KYRNF
74GF Score
Kyorin Pharmaceutical Co Ltd KYRNF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyorin Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kyorin Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=15.624/112.7000*112.7000
=15.624

Current CPI (Mar. 2026) = 112.7000.

Kyorin Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 20.131 98.100 23.127
201609 20.499 98.000 23.574
201612 18.137 98.400 20.773
201703 19.012 98.100 21.842
201706 19.436 98.500 22.238
201709 19.338 98.800 22.059
201712 19.525 99.400 22.138
201803 20.878 99.200 23.719
201806 19.807 99.200 22.503
201809 25.255 99.900 28.491
201812 18.583 99.700 21.006
201903 19.380 99.700 21.907
201906 19.452 99.800 21.966
201909 19.400 100.100 21.842
201912 19.648 100.500 22.033
202003 19.895 100.300 22.355
202006 19.953 99.900 22.510
202009 20.400 99.900 23.014
202012 20.593 99.300 23.372
202103 20.014 99.900 22.578
202106 19.190 99.500 21.736
202109 19.315 100.100 21.746
202112 18.834 100.100 21.205
202203 18.324 101.100 20.426
202206 16.286 101.800 18.030
202209 15.192 103.100 16.607
202212 16.400 104.100 17.755
202303 16.380 104.400 17.682
202306 15.401 105.200 16.499
202309 14.899 106.200 15.811
202312 15.302 106.800 16.147
202403 15.189 107.200 15.968
202406 0.000 108.200 0.000
202409 15.833 108.900 16.385
202412 14.720 110.700 14.986
202503 15.915 111.100 16.144
202506 16.403 111.700 16.550
202509 16.062 112.000 16.162
202512 15.504 113.000 15.463
202603 15.624 112.700 15.624

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $15.21 mean?
Kyorin Pharmaceutical Co (KYRNF) has a Cyclically Adjusted Book per Share of $15.21 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kyorin Pharmaceutical Co and its competitors.
Is Kyorin Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Kyorin Pharmaceutical Co's current Cyclically Adjusted Book per Share is $15.21. Overall, Kyorin Pharmaceutical Co has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Kyorin Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Kyorin Pharmaceutical Co's Cyclically Adjusted Book per Share of $15.21 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kyorin Pharmaceutical Co and its competitors. Kyorin Pharmaceutical Co's current Cyclically Adjusted Book per Share is $15.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyorin Pharmaceutical Co stock overvalued right now?
Kyorin Pharmaceutical Co (KYRNF) has a current Cyclically Adjusted Book per Share of $15.21. The stock's GF Value™ is $13.86, compared to a current price of $10.31 — trading 25.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is $15.21. Kyorin Pharmaceutical Co's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Kyorin Pharmaceutical Co (KYRNF), the current Cyclically Adjusted Book per Share is $15.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyorin Pharmaceutical Co (KYRNF) Overvalued in 2026?

Based on GuruFocus' analysis, Kyorin Pharmaceutical Co stock appears to be undervalued. The current stock price of $10.31 is trading 25.6% below its estimated GF Value™ of $13.86.

Key valuation signals for KYRNF:

  • Cyclically Adjusted Book per Share: $15.21
  • GF Value™: $13.86 vs. price of $10.31 (25.6% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the KYRNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kyorin Pharmaceutical Co Business Description

Other Exchanges 4569:Japan
Address 6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.
74GF Score

Get the complete analysis for KYRNF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.31
Price
$13.86
GF Value